daratumumab

Intermediate encouraging results from Daratumumab Pilot study in Norway n= 10 Recently in October, Norwegian researchers presented preliminary results - The initial response rate is promising and it’s well tolerated. - A larger RCT trial is going to be planned (in 2025?j It’s a 15 minute...